Literature DB >> 25065577

Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibition.

Thomas H Oguin1, Shalini Sharma2, Amanda D Stuart3, Susu Duan4, Sarah A Scott5, Carrie K Jones6, J Scott Daniels6, Craig W Lindsley7, Paul G Thomas8, H Alex Brown9.   

Abstract

Lipid metabolism plays a fundamental role during influenza virus replication, although key regulators of lipid-dependent trafficking and virus production remain inadequately defined. This report demonstrates that infection by influenza virus stimulates phospholipase D (PLD) activity and that PLD co-localizes with influenza during infection. Both chemical inhibition and RNA interference of PLD delayed viral entry and reduced viral titers in vitro. Although there may be contributions by both major isoenzymes, the effects on viral infectivity appear to be more dependent on the PLD2 isoenzyme. In vivo, PLD2 inhibition reduced virus titer and correlated with significant increases in transcription of innate antiviral effectors. The reduction in viral titer downstream of PLD2 inhibition was dependent on Rig-I (retinoic acid-inducible gene-1), IRF3, and MxA (myxovirus resistance gene A) but not IRF7. Inhibition of PLD2 accelerated the accumulation of MxA in foci as early as 30 min postinfection. Together these data suggest that PLD facilitates the rapid endocytosis of influenza virus, permitting viral escape from innate immune detection and effectors that are capable of limiting lethal infection.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Antiviral Agent; Cell Signaling; Enzyme Inhibitor; Influenza Virus; Inhibitors; Phospholipase D; Phospholipid

Mesh:

Substances:

Year:  2014        PMID: 25065577      PMCID: PMC4162146          DOI: 10.1074/jbc.M114.558817

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Influenza fusion peptides.

Authors:  J J Skehel; K Cross; D Steinhauer; D C Wiley
Journal:  Biochem Soc Trans       Date:  2001-08       Impact factor: 5.407

2.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

Review 3.  Endocytosis of influenza viruses.

Authors:  Melike Lakadamyali; Michael J Rust; Xiaowei Zhuang
Journal:  Microbes Infect       Date:  2004-08       Impact factor: 2.700

4.  Hu-K4 is a ubiquitously expressed type 2 transmembrane protein associated with the endoplasmic reticulum.

Authors:  Antonia Munck; Christopher Böhm; Nicole M Seibel; Zara Hashemol Hosseini; Wolfgang Hampe
Journal:  FEBS J       Date:  2005-04       Impact factor: 5.542

5.  Phospholipase D2 is required for efficient endocytic recycling of transferrin receptors.

Authors:  David Padrón; Renee D Tall; Michael G Roth
Journal:  Mol Biol Cell       Date:  2005-11-16       Impact factor: 4.138

6.  Role of protein kinase C betaII in influenza virus entry via late endosomes.

Authors:  Sara B Sieczkarski; H Alex Brown; Gary R Whittaker
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity.

Authors:  Vy Lam; Karen A Duca; John Yin
Journal:  Biotechnol Bioeng       Date:  2005-06-30       Impact factor: 4.530

Review 8.  Lipid rafts and HIV-1: from viral entry to assembly of progeny virions.

Authors:  S M Campbell; S M Crowe; J Mak
Journal:  J Clin Virol       Date:  2001-10       Impact factor: 3.168

9.  Phospholipase D2: functional interaction with caveolin in low-density membrane microdomains.

Authors:  M Czarny; G Fiucci; Y Lavie; Y Banno; Y Nozawa; M Liscovitch
Journal:  FEBS Lett       Date:  2000-02-11       Impact factor: 4.124

10.  Lipid raft-dependent targeting of the influenza A virus nucleoprotein to the apical plasma membrane.

Authors:  Marlene Carrasco; Maria Joao Amorim; Paul Digard
Journal:  Traffic       Date:  2004-12       Impact factor: 6.215

View more
  24 in total

Review 1.  The phospholipase D superfamily as therapeutic targets.

Authors:  Michael A Frohman
Journal:  Trends Pharmacol Sci       Date:  2015-02-03       Impact factor: 14.819

2.  Antimicrobial agent triclosan suppresses mast cell signaling via phospholipase D inhibition.

Authors:  Juyoung K Shim; Molly A Caron; Lisa M Weatherly; Logan B Gerchman; Suraj Sangroula; Siham Hattab; Alan Y Baez; Talya J Briana; Julie A Gosse
Journal:  J Appl Toxicol       Date:  2019-08-19       Impact factor: 3.446

Review 3.  Physiological and pathophysiological roles for phospholipase D.

Authors:  Rochelle K Nelson; Michael A Frohman
Journal:  J Lipid Res       Date:  2015-04-29       Impact factor: 5.922

4.  Further evaluation of novel structural modifications to scaffolds that engender PLD isoform selective inhibition.

Authors:  Matthew C O'Reilly; Sarah A Scott; H Alex Brown; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2014-11-15       Impact factor: 2.823

5.  Human phospholipase D activity transiently regulates pyrimidine biosynthesis in malignant gliomas.

Authors:  Thomas P Mathews; Salisha Hill; Kristie L Rose; Pavlina T Ivanova; Craig W Lindsley; H Alex Brown
Journal:  ACS Chem Biol       Date:  2015-02-17       Impact factor: 5.100

6.  Discovery of a highly selective PLD2 inhibitor (ML395): a new probe with improved physiochemical properties and broad-spectrum antiviral activity against influenza strains.

Authors:  Matthew C O'Reilly; Thomas H Oguin; Sarah A Scott; Paul G Thomas; Charles W Locuson; Ryan D Morrison; J Scott Daniels; H Alex Brown; Craig W Lindsley
Journal:  ChemMedChem       Date:  2014-09-10       Impact factor: 3.466

7.  Lipid composition of viral envelope of three strains of influenza virus - not all viruses are created equal.

Authors:  Pavlina T Ivanova; David S Myers; Stephen B Milne; Jennifer L McClaren; Paul G Thomas; H Alex Brown
Journal:  ACS Infect Dis       Date:  2015-06-24       Impact factor: 5.084

8.  Crystal structure of plant PLDα1 reveals catalytic and regulatory mechanisms of eukaryotic phospholipase D.

Authors:  Jianxu Li; Fang Yu; Hui Guo; Renxue Xiong; Wenjing Zhang; Fangyuan He; Minhua Zhang; Peng Zhang
Journal:  Cell Res       Date:  2019-10-16       Impact factor: 46.297

9.  Phospholipase D1 Couples CD4+ T Cell Activation to c-Myc-Dependent Deoxyribonucleotide Pool Expansion and HIV-1 Replication.

Authors:  Harry E Taylor; Glenn E Simmons; Thomas P Mathews; Atanu K Khatua; Waldemar Popik; Craig W Lindsley; Richard T D'Aquila; H Alex Brown
Journal:  PLoS Pathog       Date:  2015-05-28       Impact factor: 6.823

Review 10.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.